Teladoc Health (NYSE:TDOC) Given New $12.00 Price Target at Piper Sandler

Teladoc Health (NYSE:TDOC) had its price objective lowered by Piper Sandler from $13.00 to $12.00 in a research report report published on Thursday,Benzinga reports. The firm currently has an overweight rating on the health services provider’s stock.

Several other equities research analysts also recently commented on TDOC. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a report on Thursday. The Goldman Sachs Group increased their price target on shares of Teladoc Health from $14.00 to $16.00 and gave the company a “buy” rating in a research note on Tuesday, February 18th. Bank of America boosted their price objective on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research note on Wednesday, February 12th. Deutsche Bank Aktiengesellschaft upped their target price on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a report on Friday, November 1st. Finally, Royal Bank of Canada lifted their price target on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Eleven equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $11.44.

Teladoc Health Trading Down 14.2 %

Shares of NYSE:TDOC opened at $9.43 on Thursday. The company’s 50-day moving average price is $10.62 and its two-hundred day moving average price is $9.53. Teladoc Health has a one year low of $6.76 and a one year high of $15.95. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The stock has a market capitalization of $1.62 billion, a PE ratio of -1.64 and a beta of 1.04.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. On average, equities analysts forecast that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of Teladoc Health stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the sale, the insider now owns 2,890 shares in the company, valued at $34,477.70. The trade was a 45.25 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.95% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Whipplewood Advisors LLC bought a new stake in shares of Teladoc Health in the fourth quarter valued at approximately $29,000. Versant Capital Management Inc raised its holdings in Teladoc Health by 313.8% in the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 2,441 shares in the last quarter. Lindbrook Capital LLC lifted its position in shares of Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock valued at $33,000 after acquiring an additional 1,612 shares during the period. Blue Trust Inc. grew its holdings in shares of Teladoc Health by 84.5% during the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after purchasing an additional 1,854 shares in the last quarter. Finally, Sterling Capital Management LLC increased its position in shares of Teladoc Health by 776.7% in the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock worth $42,000 after purchasing an additional 4,101 shares during the period. 76.82% of the stock is owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.